WA
CELG

WealthTrust Axiom’s Celgene Corp CELG Stock Holding History

WealthTrust Axiom’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,714
Closed -$337K – 239
2017
Q1 		$337K Hold
2,714
– – 0.12% 141
2016
Q4 		$314K Sell
2,714
-86
-3% -$9.58K 0.11% 153
2016
Q3 		$292K Buy
2,800
+650
+30% +$70.3K 0.11% 152
2016
Q2 		$212K Hold
2,150
– – 0.08% 188
2016
Q1 		$215K Buy
2,150
+150
+8% +$15.4K 0.08% 180
2015
Q4 		$239K Hold
2,000
– – 0.09% 167
2015
Q3 		$216K Hold
2,000
– – 0.09% 176
2015
Q2 		$231K Hold
2,000
– – 0.09% 182
2015
Q1 		$230K Hold
2,000
– – 0.08% 185
2014
Q4 		$223K Buy
+2,000
New +$211K 0.08% 185

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WealthTrust Axiom's CELG Position: Q2 2017 in Review

WealthTrust Axiom sold out of Celgene Corp (CELG) in Q2 2017, closing a stake of 2,714 shares — an estimated $337K sold.

WealthTrust Axiom first reported a position in CELG in Q4 2014 and held it in 10 quarters. The position peaked at $337K in Q1 2017. 1,428 funds tracked by Wall St. Rank hold CELG as of Q2 2017.

  • WealthTrust Axiom reported no remaining Celgene Corp position as of Q2 2017 after selling out during the quarter.
  • WealthTrust Axiom sold 2,714 Celgene Corp shares in Q2 2017, an estimated $337K.
  • WealthTrust Axiom first reported a position in Celgene Corp in Q4 2014 and held it in 10 quarters.
  • WealthTrust Axiom's Celgene Corp position peaked at $337K in Q1 2017.
  • 1,428 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2017.

Based on WealthTrust Axiom's 13F filing for Q2 2017, filed 31 Jul 2017.